Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
- PMID: 10658181
Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
Abstract
Although the CLN3 gene for Batten disease, the most common inherited neurovisceral storage disease of childhood, was identified in 1995, the function of the corresponding protein still remains elusive. A key to understanding the pathology of this devastating disease will be to elucidate the function of CLN3 at the molecular level. CLN3 has proven difficult to study, as it is predicted to be a membrane protein, and is of apparently low abundance in cells. Different groups have reported differing subcellular localization of CLN3. The purpose of this review is to critically examine the various cell biological approaches undertaken to localize CLN3 and to piece together a potential function for CLN3 in neuronal cells. The most likely conclusion of this is that CLN3 is a lysosomal/endosomal protein that is trafficked through the endoplasmic reticulum (ER) and Golgi. Furthermore, studies are required to confirm whether CLN3 has a potential role in the recycling of synaptic vesicles through the endosome/lysosome.
Similar articles
-
Intracellular trafficking of the JNCL protein CLN3.Mol Genet Metab. 1999 Apr;66(4):253-60. doi: 10.1006/mgme.1999.2802. Mol Genet Metab. 1999. PMID: 10191111
-
Investigation of Batten disease with the yeast Saccharomyces cerevisiae.Mol Genet Metab. 1999 Apr;66(4):314-9. doi: 10.1006/mgme.1999.2820. Mol Genet Metab. 1999. PMID: 10191120
-
CLN3, the protein associated with batten disease: structure, function and localization.J Neurosci Res. 2005 Mar 1;79(5):573-83. doi: 10.1002/jnr.20367. J Neurosci Res. 2005. PMID: 15657902 Review.
-
Tissue expression and subcellular localization of CLN3, the Batten disease protein.Mol Genet Metab. 1999 Apr;66(4):283-9. doi: 10.1006/mgme.1999.2830. Mol Genet Metab. 1999. PMID: 10191116
-
The CLN3 gene and protein: What we know.Mol Genet Genomic Med. 2019 Dec;7(12):e859. doi: 10.1002/mgg3.859. Epub 2019 Sep 30. Mol Genet Genomic Med. 2019. PMID: 31568712 Free PMC article. Review.
Cited by
-
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse.Am J Hum Genet. 2002 Feb;70(2):324-35. doi: 10.1086/338190. Epub 2001 Dec 21. Am J Hum Genet. 2002. PMID: 11791207 Free PMC article.
-
A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.Commun Biol. 2021 Feb 5;4(1):161. doi: 10.1038/s42003-021-01682-5. Commun Biol. 2021. PMID: 33547385 Free PMC article.
-
Cell biology of membrane trafficking in human disease.Int Rev Cytol. 2006;252:1-69. doi: 10.1016/S0074-7696(06)52005-4. Int Rev Cytol. 2006. PMID: 16984815 Free PMC article. Review.
-
The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.Neuromolecular Med. 2002;1(2):111-24. doi: 10.1385/NMM:1:2:111. Neuromolecular Med. 2002. PMID: 12025857 Review.
-
Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).Ann N Y Acad Sci. 2016 May;1371(1):55-67. doi: 10.1111/nyas.12990. Epub 2016 Jan 8. Ann N Y Acad Sci. 2016. PMID: 26748992 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources